Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Transgenic animals in inflammatory disease models.

Carrie M Brodmerkel¹, Krishna Vaddi

¹Incyte Corporation, Building 400, Rte 141 and Henry Clay Road, Wilmington, DE 19880, USA.

Current Opinion in Biotechnology

|December 10, 2003

Summary

Transgenic technology aids in understanding inflammatory diseases by modeling human conditions in animals. This approach enhances research into conditions like rheumatoid arthritis and multiple sclerosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab.

Nature biotechnology·2011

Same author

Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.

Bioorganic & medicinal chemistry letters·2010

Same author

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.

Bioorganic & medicinal chemistry letters·2008

Same author

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.

Bioorganic & medicinal chemistry letters·2008

Same author

Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).

Bioorganic & medicinal chemistry letters·2008

Same author

Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).

Bioorganic & medicinal chemistry letters·2007

Area of Science:

Immunology and Genetics
Pathogenesis Research

Background:

Inflammatory diseases are a global health concern, extensively studied for decades.
Transgenic technology offers advanced tools for dissecting disease mechanisms.
Understanding genetic contributions is key to developing effective treatments.

Purpose of the Study:

To explore the utility of transgenic animal models in studying inflammatory diseases.
To highlight recent advancements in understanding specific inflammatory conditions using these models.

Main Methods:

Utilizing established inflammatory disease models in transgenic animals.
Identifying novel disease models through spontaneous genetic mutations.
Applying transgenic approaches to human inflammatory disease models.

Related Experiment Videos

Main Results:

Significant progress in understanding rheumatoid arthritis.
Advances in pulmonary inflammation research.
New insights into multiple sclerosis pathogenesis.
Improved models for inflammatory bowel disease study.

Conclusions:

Transgenic animal models are crucial for elucidating inflammatory disease mechanisms.
These models facilitate the study of genetic contributions to disease.
Recent research demonstrates the power of transgenic technology in advancing human inflammatory disease understanding.